Parse Biosciences
Parse Bio is a biotechnology startup company developing single-cell sequencing kit solutions for researchers. By using combinatorial cDNA barcoding within cells themselves, Parse Biosciences’s technology allows researchers to eliminate the need for complex and expensive microfluidic instruments. Additionally, the company’s technology enables samples to be fixed, frozen, and stored, allowing researchers to separate out the sample extraction from downstream library preparation steps. This capability empowers researchers to run fixed samples collected on different dates together in a single experiment, providing greater control over sample handling and reducing handling errors. Split Biosciences rebranded as Parse Biosciences in 2020. The Seattle, Washington-based biotech company was established in 2018 by Alex Rosenberg, Charlie Roco, and Georg Friedrich Seelig.
Domain
parsebiosciences.com
Country
United StatesIndustry
BioinformaticsEmployees
101-250
Last Funding
$50.0M
Founded
2017
Tech Stack (29 technologies)
Frequently Asked Questions
What technologies does Parse Biosciences use?+
Parse Biosciences uses 29 technologies including Bootstrap, Facebook Pixel, Google Tag Manager.
What industry is Parse Biosciences in?+
Parse Biosciences operates in the Bioinformatics industry.
Where is Parse Biosciences based?+
Parse Biosciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026